Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Allergy Thera. (AGY) Regulatory News

Date Source Headline
20th Apr 2023 5:29 pm RNS Project Zebra Rule 2.9 Announcement
19th Apr 2023 7:00 am RNS Skin-prick testing completes in PROTECT Trial
17th Apr 2023 2:30 pm RNS Form 8 OPD SkyGem Acquisition Limited Replacement
17th Apr 2023 10:30 am RNS Form 8 (OPD) SkyGem Acquisition Limited
11th Apr 2023 10:10 am BUS Form 8.3 - The Allergy Therapeutics Plc
6th Apr 2023 2:01 pm RNS £40.75 million Facility with Equity Financing
6th Apr 2023 2:01 pm RNS Statement Regarding Possible Mandatory Cash Offer
6th Apr 2023 2:00 pm RNS Trading and Business Update
29th Mar 2023 7:00 am RNS Publication of Interim Results Delayed
27th Mar 2023 7:00 am RNS Patients dosed in VLP Peanut PROTECT trial
8th Mar 2023 5:28 pm RNS Block Listing Interim Review
3rd Mar 2023 7:00 am RNS PDMR Dealing
7th Feb 2023 6:29 pm RNS Result of AGM
20th Jan 2023 7:00 am RNS Half-Year Trading Update 2023
13th Jan 2023 5:27 pm RNS NOTICE OF 2022 ANNUAL GENERAL MEETING
3rd Jan 2023 7:30 am RNS Suspension - Allergy Therapeutics plc
29th Dec 2022 11:05 am RNS Second Price Monitoring Extn
29th Dec 2022 11:00 am RNS Price Monitoring Extension
29th Dec 2022 9:05 am RNS Second Price Monitoring Extn
29th Dec 2022 9:00 am RNS Price Monitoring Extension
29th Dec 2022 7:00 am RNS Annual Report and Accounts Delayed
28th Dec 2022 7:00 am RNS Director Resignation
8th Dec 2022 7:00 am RNS Key updates on Grass MATA MPL and VLP Peanut
6th Dec 2022 7:00 am RNS Appointment of Non-Executive Directors
21st Nov 2022 7:00 am RNS Appointment of Interim CFO
28th Oct 2022 7:00 am RNS Allergy to resume UK manufacturing production
19th Oct 2022 3:39 pm RNS Holding(s) in Company
17th Oct 2022 1:27 pm RNS Allergy Therapeutics – Result of GM
4th Oct 2022 7:00 am RNS UK manufacturing update
29th Sep 2022 12:00 pm RNS Allergy Therapeutics at Investor Meet Company
29th Sep 2022 7:00 am RNS Subscription and Debt Financing
29th Sep 2022 7:00 am RNS Unaudited Preliminary Results 2022
5th Sep 2022 7:00 am RNS Allergy Therapeutics at H.C. Wainwright Conference
2nd Sep 2022 4:50 pm RNS Total Voting Rights
2nd Aug 2022 12:58 pm RNS Block Listing Interim Review
15th Jul 2022 7:00 am RNS Trading Update and Notice of Results
1st Jul 2022 7:00 am RNS Allergy Therapeutics at EAACI Congress 2022
26th May 2022 7:00 am RNS Nick Wykeman to step down as CFO
23rd May 2022 7:00 am RNS Allergy Therapeutics at H.C. Wainwright Conference
25th Apr 2022 7:00 am RNS Allergy Therapeutics shares data at WAO-BSACI
FTSE 100 Latest
Value9,546.60
Change-5.70